Richard
Kelly
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, CB4 0WF, UK. E-mail: medchemcomm-rsc@rsc.org
First published on 19th November 2015
Expression of concern for ‘Identifying the inhibitory mechanism of apigenin on the insulin ligand–receptor binding’ by Yong Yang, Med. Chem. Commun., 2015, 6, 1190–1195.
The Royal Society of Chemistry has been contacted by the author of this article to inform us of a problem with the authorship and some portions of text overlap, which the author attributes to an editing company.
Upon close examination the Executive Editor has found extensive text overlap with a previously published paper by Yong Yang and a co-author (Quercetin suppresses insulin receptor signaling through inhibition of the insulin ligand–receptor binding and therefore impairs cancer cell proliferation, Feng Wang and Yong Yang, Biochemical and Biophysical Research Communications, 2014, 452, 1028–1033). Further to this the Executive Editor has significant concerns over the validity of the reported findings.
MedChemComm is publishing this expression of concern in order to alert readers to these concerns as the on-going investigation is expected to take a significant amount of time to complete. The Royal Society of Chemistry is currently seeking support from the affiliated institution in order to investigate the matter and establish whether the reported results are sound.
This notice will be updated when a final outcome is reached.
Richard Kelly
11th November 2015
Executive Editor, MedChemComm
This journal is © The Royal Society of Chemistry 2015 |